| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |